Abstract
Cytomegalovirus (CMV) is the most frequent congenital infection and the leading cause of nongenetic sensorineural hearing loss (SNHL) in children worldwide. Congenital CMV (cCMV) infection (cCMVI) may be asymptomatic or symptomatic at birth. Although the minority of infants with cCMVI have symptoms at birth, these symptomatic infants are at significant risk for long-term sequelae. Sensorineural hearing loss (HL) is the most common sequela of cCMVI and can occur in asymptomatic and symptomatic cases [1, 2]. The association between cCMVI and HL was first described by Medearis in 1964 [3] and has been further described in numerous longitudinal studies since that time [4].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Harrison GJ. Cytomegalovirus. In: Cherry JD, Harrison GJ, Kaplan SL, Steinbach WJ, Hotez PJ, editors. Feigin and Cherry’s textbook of pediatric infectious diseases. 8th ed. Philadelphia: Elsevier; 2019. p. 1429–50.
Ross SA. Cytomegalovirus. In: Long SS, Prober CG, Fischer M, Kimberlin DW, editors. Principles and practice of pediatric infectious diseases. 6th ed. Philadelphia: Elsevier; 2023. p. 1092–9.
Medearis DN Jr. Viral infections during pregnancy and abnormal human development. Am J Obstet Gynecol. 1964;90(suppl):1140–8.
Fowler KB. Congenital cytomegalovirus infection: audiologic outcome. Clin Infect Dis. 2013;57:S182–4.
Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17:253–76.
Zuhair M, Smit GSA, Wallis G, et al. Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis. Rev Med Virol. 2019;29(3):e2034.
Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013;26:86–102.
Maltezou PG, Kourlaba G, Kourkouni Ε, et al. Maternal type of CMV infection and sequelae in infants with congenital CMV: systematic review and meta-analysis. J Clin Virol. 2020;129:104518.
Wang C, Zhang X, Bialek S, Cannon MJ. Attribution of congenital cytomegalovirus infection to primary versus nonprimary maternal infection. Clin Infect Dis. 2011;52(2):e11–3.
de Vries JJ, van Zwet EW, Dekker FW, et al. The apparent paradox of maternal seropositivity as a risk factor for congenital cytomegalovirus infection: a population-based prediction model. Rev Med Virol. 2013;23:241–9.
Fowler KB, Stagno S, Pass RF, et al. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med. 1992;326:663–7.
Stagno S, Pass RF, Cloud G, et al. Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA. 1986;256:1904–8.
Chatzakis C, Ville Y, Makrydimas G, et al. Timing of primary maternal cytomegalovirus infection and rates of vertical transmission and fetal consequences. Am J Obstet Gynecol. 2020;223:870–883.e11.
Elkan Miller T, Weisz B, Yinon Y, et al. Congenital cytomegalovirus infection following second and third-trimester maternal infection is associated with mild childhood adverse outcomes not predicted by prenatal imaging. J Pediatric Infect Dis Soc. 2021;10:562–8.
Picone O, Teissier N, Cordier AG, et al. Detailed in utero ultrasound description of 30 cases of congenital cytomegalovirus infection. Prenat Diagn. 2014;34:518–24.
Lanzieri TM, Chung W, Flores M, et al. Hearing loss in children with asymptomatic congenital cytomegalovirus infection. Pediatrics. 2017;139:e20162610.
Bartlett AW, McMullan B, Rawlinson WD, Palasanthiran P. Hearing and neurodevelopmental outcomes for children with asymptomatic congenital cytomegalovirus infection: a systematic review. Rev Med Virol. 2017. https://doi.org/10.1002/rmv.1938.
Jin HD, Demmler-Harrison GJ, Coats DK, et al. Long-term visual and ocular sequelae in patients with congenital cytomegalovirus infection. Pediatr Infect Dis J. 2017;36:877–82.
Coats DK, Demmler GJ, Paysse EA, Du LT, Libby C. Ophthalmologic findings in children with congenital cytomegalovirus infection. J AAPOS. 2000;4:110–6.
Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17:355–63.
Rawlinson WD, Boppana SB, Fowler KB, et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis. 2017;17:e177–88.
Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J. 1992;11:93–9.
Fink KR, Thapa MM, Ishak GE, Pruthi S. Neuroimaging of pediatric central nervous system cytomegalovirus infection. Radiographics. 2010;30:1779–96.
Dreher AM, Arora N, Fowler KB, et al. Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection. J Pediatr. 2014;164:855–9.
Lopez AS, Lanzieri TM, Claussen AH, et al. Intelligence and academic achievement with asymptomatic congenital cytomegalovirus infection. Pediatrics. 2017;140:e2017151.
Pinninti S, Christy J, Almutairi A, et al. Vestibular, gaze, and balance disorders in asymptomatic congenital cytomegalovirus infection. Pediatrics. 2021;147:e20193945.
Goderis J, De Leenheer E, Smets K, et al. Hearing loss and congenital CMV infection: a systematic review. Pediatrics. 2014;134:972–82.
Fletcher KT, Horrell EMW, Ayugi J, et al. The natural history and rehabilitative outcomes of hearing loss in congenital cytomegalovirus: a systematic review. Otol Neurotol. 2018;39:854–64.
Vos B, Noll D, Whittingham J, et al. Cytomegalovirus—a risk factor for childhood hearing loss: a systematic review. Ear Hear. 2021;42:1447–61.
Dahle AJ, Fowler KB, Wright JD, et al. Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J Am Acad Audiol. 2000;11:283–90.
Goderis J, Keymeulen A, Smets K, et al. Hearing in children with congenital cytomegalovirus infection: results of a longitudinal study. J Pediatr. 2016;172:110–5.
Riga M, Korres G, Chouridis P, Naxakis S, Danielides V. Congenital cytomegalovirus infection inducing non-congenital sensorineural hearing loss during childhood: a systematic review. Int J Pediatr Otorhinolaryngol. 2018;115:156–64.
Jenks CM, Mithal LB, Hoff SR. Early identification and management of congenital cytomegalovirus. Otolaryngol Clin North Am. 2021;54:1117–27.
Fowler KB, McCollister FP, Dahle AJ, et al. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr. 1997;130:624–30.
Luck SE, Wieringa JW, Blázquez-Gamero D, et al. Congenital cytomegalovirus: a European expert consensus statement on diagnosis and management. Pediatr Infect Dis J. 2017;36:1205–13.
Cannon MJ, Griffiths PD, Aston V, Rawlinson WD. Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit? Rev Med Virol. 2014;24:291–307.
Demmler Harrison GJ. Newborn screening for congenital cytomegalovirus infection… it is time. Clin Infect Dis. 2020;70:1385–7.
Bergevin A, Zick CD, McVicar SB, Park AH. Cost-benefit analysis of targeted hearing directed early testing for congenital cytomegalovirus infection. Int J Pediatr Otorhinolaryngol. 2015;79:2090–3.
Fowler KB, McCollister FP, Sabo DL, et al. A targeted approach for congenital cytomegalovirus screening within newborn hearing screening. Pediatrics. 2017;139(2):e20162128.
Yamamoto AY, Mussi-Pinhata MM, Marin LJ, et al. Is saliva as reliable as urine for detection of cytomegalovirus DNA for neonatal screening of congenital CMV infection? J Clin Virol. 2006;36:228–30.
Lazzarotto T, Blázquez-Gamero D, Delforge ML, et al. Congenital cytomegalovirus infection: a narrative review of the issues in screening and management from a panel of European experts. Front Pediatr. 2020;8:13.
Dollard SC, Dreon M, Hernandez-Alvarado N, et al. Sensitivity of dried blood spot testing for detection of congenital cytomegalovirus infection. JAMA Pediatr. 2021;175:e205441.
Gwee A, Curtis N, Connell TG, Garland S, Daley AJ. Ganciclovir for the treatment of congenital cytomegalovirus: what are the side effects? Pediatr Infect Dis J. 2014;33:115.
Swanson EC, Schleiss MR. Congenital cytomegalovirus infection: new prospects for prevention and therapy. Pediatr Clin North Am. 2013;60:335–49.
Tol I, Heath PT, Khalil A. Prevention strategies for congenital cytomegalovirus infection. Curr Opin Infect Dis. 2021;34:546–51.
Hughes BL, Clifton RG, Rouse DJ, et al. A trial of hyperimmune globulin to prevent congenital cytomegalovirus infection. N Engl J Med. 2021;385:436–44.
Shahar-Nissan K, Pardo J, et al. Valaciclovir to prevent vertical transmission of cytomegalovirus after primary maternal infection during pregnancy: a randomised, double-blind, placebo-controlled trial. Lancet. 2020;396:779–85.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Polat, M., Arısoy, A.E., Demmler-Harrison, G.J. (2023). Congenital Cytomegalovirus Infection and Hearing Loss. In: Arısoy, A.E., Arısoy, E.S., Bayar Muluk, N., Cingi, C., Correa, A.G. (eds) Hearing Loss in Congenital, Neonatal and Childhood Infections. Comprehensive ENT. Springer, Cham. https://doi.org/10.1007/978-3-031-38495-0_7
Download citation
DOI: https://doi.org/10.1007/978-3-031-38495-0_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-38494-3
Online ISBN: 978-3-031-38495-0
eBook Packages: MedicineMedicine (R0)